The clinical performance is complex and often involves multi-system fatigue. Early identification and standardized clinical care are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PML immune re-inflammatory syndrome require individualized development, usually including multidimensional management of prognosis, including drug therapy, rehabilitation, regular follow-up visits, and more. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of PML immune rebuilding inflammatory syndrome. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.